Exploring Heteroplasmic Variants in mtDNA: Insights from Single-Cell Transcriptomics
Cells · 03.08.2026 · 15 (15) · 1403
DOI: 10.3390/cells15151403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 03.08.2026. Verfasst von Marco Barresi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20126 Milan, Italy. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Single-Cell Analysis, Heteroplasmy, Transcriptome. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Ministry of Health.
Abstract (Originalsprache)
Mitochondrial DNA (mtDNA) heteroplasmy, which is the coexistence of wild-type and mutant mtDNA variants within the same cell, plays a critical role in modulating cellular phenotypes, disease severity, and penetrance. Bulk RNA sequencing cannot detect cell-to-cell heteroplasmy variability, limiting our understanding of the pathological mechanisms of mtDNA variants. In this study, we leveraged single-cell RNA sequencing (scRNA-seq) combined with a robust bioinformatics pipeline to characterize mtDNA heteroplasmy. We employed four fibroblast lines from patients harboring heteroplasmic mtDNA pathogenic variants in genes encoding respiratory complex I subunits. While RNA heteroplasmy corresponded to DNA-based measurements at the bulk level, single-cell analysis uncovered a diverged distribution in three out of four lines: most cells had near-homoplasmic (wild-type or mutant) mtDNA, with few cells showing intermediate levels. Furthermore, we found that high mutation levels correlate with transcriptional profile changes, although these responses were highly sample-specific, suggesting that the nuclear background and cellular context critically influence mitochondrial dysfunction and compensatory mechanisms. Our findings highlight the potential of single-cell technologies to better understand the complex link between mtDNA genetic diversity and mitochondrial phenotypic variability and to study crucial aspects of mitochondrial biology and pathology, such as clonal dynamics, at single-cell resolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20126 Milan, Italy.
- Department of Pathophysiology and Transplantation (DEPT), University of Milan, 20122 Milan, Italy.
ORCID-Profile: Marco Barresi, Ivano Di Meo, Alessia Nasca, Eleonora Lamantea, Andrea Legati, Daniele Ghezzi
Förderung
- European Union
- Ministry of Health
Zitieren
APA
Barresi, M., Di Meo, I., Nasca, A., Lamantea, E., Legati, A., & Ghezzi, D. (2026). Exploring Heteroplasmic Variants in mtDNA: Insights from Single-Cell Transcriptomics. Cells, 15(15), 1403. https://doi.org/10.3390/cells15151403
Vancouver
Barresi M, Di Meo I, Nasca A, Lamantea E, Legati A, Ghezzi D. Exploring Heteroplasmic Variants in mtDNA: Insights from Single-Cell Transcriptomics. Cells. 2026;15(15):1403. doi:10.3390/cells15151403
BibTeX
@article{Barresi2026,
author = {Barresi, Marco and Di Meo, Ivano and Nasca, Alessia and Lamantea, Eleonora and Legati, Andrea and Ghezzi, Daniele},
title = {Exploring Heteroplasmic Variants in mtDNA: Insights from Single-Cell Transcriptomics},
journal = {Cells},
year = {2026},
volume = {15},
number = {15},
pages = {1403},
doi = {10.3390/cells15151403}
}
EUVIMED